Patent · US Active

Medical treatments based on anamorelin

US11723902B2 · kind B2 · utility

0Cited by

4References

12Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

William R. Mann · Hoboken, US
John FRIEND · Colts Neck Township, US
William J. Polvino · Edison, US
Suzan ALLEN · Georgetown, US
Ming Lu · Plainsboro, US
Elizabeth Duus · Cape Coral, US
Ruben Giorgino · Allschwil, CH
Enrico Baroni · Cernobbio, IT

Key dates

Filing date	Dec 11, 2020
Grant date	Aug 15, 2023
Priority date	—
Expiry date	May 3, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of treating cancer related conditions using anamorelin are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.